# Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE)

> **NCT05766124** · PHASE2,PHASE3 · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 30 (estimated)

## Conditions studied

- Pleural Infection

## Interventions

- **DRUG:** Tissue Plasminogen Activator

## Key facts

- **NCT ID:** NCT05766124
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05766124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05766124, "Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05766124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*